Related Experiment Video
Updated: Jun 25, 2026
Establishment of a High-throughput Setup for Screening Small Molecules That Modulate c-di-GMP Signaling in Pseudomonas aeruginosa
Published on: June 30, 2016
A p38 mitogen-activated protein kinase inhibitor screening method using growth recovery of Escherichia coli as an
Kayoko Kawai1, Akiko Saito, Tatsuhiko Sudo
1Antibiotics Laboratory and Bioarchitect Research Group, RIKEN Advanced Science Institute, Wako, Saitama 351-0198, Japan.
Abstract:
The p38 mitogen-activated protein (MAP) kinase is the central signaling molecule regulating the cellular response to a multitude of external stimuli. Thus, inhibitors of this enzyme are postulated to have significant therapeutic potential for the treatment of some diseases, especially where aberrant cytokine signaling is the driver of disease. Here we established a simple inhibitor screening method for a human protein by using bacteria in combination with the growth recovery as an index. The screening successfully identified benzyl coumarin derivatives as p38 inhibitors. These compounds not only rescue growth retardation of p38-transformed bacteria but also inhibit p38 activity in vitro and in human cells. This study demonstrates that this is a promising and economical inhibitor screening method not only for p38 but also for other proteins.
Insights
Researchers developed a cost-effective bacterial screening method to identify inhibitors for p38 mitogen-activated protein (MAP) kinase. Benzyl coumarin derivatives were found to inhibit p38 kinase activity in bacteria, in vitro, and in human cells.
Area of Science:
- Biochemistry
- Molecular Biology
- Drug Discovery
Background:
- p38 mitogen-activated protein (MAP) kinase is crucial for cellular responses to stimuli.
- Aberrant p38 signaling drives diseases, making its inhibitors therapeutically relevant.
- Targeting p38 kinase is a key strategy in treating inflammatory and other diseases.
Purpose of the Study:
- To establish a simple, economical screening method for human protein inhibitors using bacteria.
- To identify novel inhibitors of p38 MAP kinase.
- To validate the efficacy of identified inhibitors in various biological systems.
Main Methods:
- Developed a bacterial-based screening assay utilizing growth recovery as a readout for inhibitor activity.
- Screened a library of compounds to identify p38 MAP kinase inhibitors.
- Validated inhibitor efficacy using in vitro biochemical assays and human cell-based models.
Main Results:
- Successfully identified benzyl coumarin derivatives as potent inhibitors of p38 MAP kinase.
- Demonstrated that these compounds rescue growth defects in p38-transformed bacteria.
- Confirmed inhibition of p38 activity in vitro and in human cells.
Conclusions:
- The bacterial screening method is a promising and economical approach for identifying protein inhibitors.
- Benzyl coumarin derivatives are effective p38 MAP kinase inhibitors with therapeutic potential.
- This screening strategy can be applied to discover inhibitors for other protein targets.
